C12N 2501/2309
Interleukin-9
Official title: Interleukin-9 (IL-9)
C12N2501/2309 (Interleukin-9) appears on 23 US grants and 35 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 35
- Assignees
- 17
- Inventors
- 56
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 3 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 2 | 5 |
| 2019 | 1 | 0 |
| 2020 | 1 | 3 |
| 2021 | 2 | 5 |
| 2022 | 4 | 2 |
| 2023 | 2 | 4 |
| 2024 | 3 | 2 |
| 2025 | 3 | 3 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for production of platelets from pluripotent stem cells and compositions thereof4 Aug 2026US RE50,977 E1Astellas Institute for Regenerative Medicine
- Methods for production of platelets from pluripotent stem cells and compositions thereof16 Jun 2026US 12,653,840 B2Astellas Institute for Regenerative Medicine
- Methods for production of platelets from pluripotent stem cells and compositions thereof16 Jun 2026US RE50,916 E1Astellas Institute for Regenerative Medicine
- Compositions for drug delivery and methods of use thereof16 Dec 2025US 12,496,315 B2Stellular Bio, Inc.
- Expansion of γδ T cells, compositions, and methods of use thereof4 Nov 2025US 12,458,698 B2GammaDelta Therapeutics Ltd
- Expansion of gamma delta t cells, compositions, and methods of use thereof25 Jun 2026US 2026/0174861 A1GammaDelta Therapeutics Ltd
- Compositions for Drug Delivery and Methods of Use Thereof12 Mar 2026US 2026/0069632 A1Stellular Bio, Inc.
- Compositions for Drug Delivery and Methods of Use Thereof26 Feb 2026US 2026/0053857 A1Stellular Bio, Inc.
- Methods for production of platelets from pluripotent stem cells and compositions thereof27 Mar 2025US 2025/0099505 A1Astellas Institute for Regenerative Medicine
- Methods for production of platelets from pluripotent stem cells and compositions thereof20 Mar 2025US 2025/0090586 A1Astellas Institute for Regenerative Medicine
Most cited
By later US patents
- Methods for production of platelets from pluripotent stem cells and compositions thereof18US 9,763,984 B2Astellas Institute for Regenerative Medicine · 2017
- Methods for production of platelets from pluripotent stem cells and compositions thereof17US 10,426,799 B2Astellas Institute for Regenerative Medicine · 2019
- Methods for production of platelets from pluripotent stem cells and compositions thereof17US 9,993,503 B2Astellas Institute for Regenerative Medicine · 2018
- Methods for production of platelets from pluripotent stem cells and compositions thereof12US 10,894,065 B2Astellas Institute for Regenerative Medicine · 2021
- Methods for production of platelets from pluripotent stem cells and compositions thereof7US 11,400,118 B2Astellas Institute for Regenerative Medicine · 2022